Subgroup analysis showed that patients with a history of liver cirrhosis, patients who were positive for HBsAg, patients who were positive for AFP, patients with vascular invasion and patients with tumor capsule infiltration had significantly higher MALAT1 expression than the corresponding patient subgroups without these characteristics (all p < 0.05). The gene discussed is MALAT1; the disease is cirrhosis of liver.